Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Swiss healthcare market: regulatory environment
Constant pressure on drug prices
Annual savings per channel at public and ex-factory price
in million CHF
Price reduction rounds
250.0
■Pharmacies
■Physicians
■Hospitals
225.5
44.6
200.0
184.7
64.8
41.0
150.0
122.3
52.4
118.0
13.4
101.3
100.3
19.3
94.4
100.0
116.1
87.0
30.9
12.1
91.3
33.2
17.1
34.3
24.6
31.5
?
78.0
25.9
?
50.0
64.6
65.5
27.8
23.6
51.4
54.2
46.1
38.2
31.9
Public price Ex-factory
price
2017
Public price Ex-factory
price
Public price Ex-factory
price
Public price Ex-factory
price
Public price Ex-factory
price
2018
2019
2020
2021 prov.
Drug prices reviewed in three-year cycles
Analysis FOPH price reductions October 2021 - Source: IQVIA APO/SD/SPI SL products, based on input FOPH
08/08/22
35
GALENICAView entire presentation